share_log

Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Beryl Capital Management LLC(0%),Beryl Capital Management LP(0%), etc.

Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Beryl Capital Management LLC(0%),Beryl Capital Management LP(0%)等

2022/02/11 18:51
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息